ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 112535 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 112535; 2) Community: the network communities that were significantly associated with the response to NSC 112535; 3) Molecule: the relationships between components within communities and NSC 112535; 4) MDR: the compounds that were significantly associated with the NSC 112535.

NSC Compound Enrichment Correlation
NSC 301189 Piperidinium, 1-[4-(4-nitrophenyl)-1,3-dithiol-2-ylidene]-, sulfate (1:1) 0.00587884296262138 0.17708664
NSC 3074 s-Triazine, 4,6-diamino-1-(p-chlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.00587884296262138 0.32112543
NSC 35753 Pyrocatechol, 4,4'-(meso-1,2-diethylethylene)di- 0.00587884296262138 0.10428959
NSC 628301 Null 0.00587884296262138 0.25469785
NSC 678994 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- 0.00587884296262138 -0.0061643269
NSC 681151 Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl] amino]-, 1-adamantyl ester 0.00587884296262138 0.035612146
NSC 687015 Null 0.00587884296262138 0.21167656
NSC 684836 Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.00623623671415521 0.039753751
NSC 689620 Null 0.00623623671415521 0.10965217
NSC 696254 Null 0.00623623671415521 0.30381074
Total:66  Current:8    [First] [Prev] [Next] [Last]